✦ LIBER ✦

Efficacy and safety of capecitabine as maintenance treatment after first-line chemotherapy using oxaliplatin and capecitabine in advanced gastric adenocarcinoma patients: a prospective observation

✍ Scribed by Qiu, Miao-zhen; Wei, Xiao-li; Zhang, Dong-sheng; Jin, Ying; Zhou, Yi-xin; Wang, De-shen; Ren, Chao; Bai, Long; Luo, Hui-yan; Wang, Zhi-qiang; Wang, Feng-hua; Li, Yu-hong; Yang, Da-jun; Xu, Rui-hua

Book ID: 121531931
Publisher: S. Karger AG
Year: 2014
Tongue: English
Weight: 271 KB
Volume: 35
Category: Article
ISSN: 1010-4283
DOI: 10.1007/s13277-013-1574-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of a combination of doc

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer

✍ Yoon-Koo Kang; Min-Hee Ryu; Changhoon Yoo; Heung-Moon Chang; Jeong Hwan Yook; Su 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 334 KB

Biweekly docetaxel, fluorouracil, leucov

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort

✍ Pernot, Simon; Mitry, Emmanuel; Samalin, Emmanuelle; Dahan, Laetitia; Dalban, CÃ 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 216 KB

6600 POSTER A Randomized, Multicenter, O

6600 POSTER A Randomized, Multicenter, Open-label, Phase III Study to Compare the Efficacy and Safety of Capecitabine Plus Paclitaxel Followed by Capecitabine Maintenance (PX-X) With Capecitabine Plus Cisplatin (XP) as a First-line Chemotherapy for Recurrent or Metastatic Gastric Cancer (PAC-C Study)

✍ Zhang, X.; Shen, L.; Lu, Z.; Hu, B.; Fan, Q.; Li, W.; Liu, W.; Liu, T.; Pan, Y.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

6504 ORAL Safety and Efficacy of Epirubi

6504 ORAL Safety and Efficacy of Epirubicin, Cisplatin, and Capecitabine (ECX) Plus Rilotumumab (R) as First-line Treatment for Unresectable Locally Advanced (LA) or Metastatic (M) Gastric or Esophagogastric Junction (EGJ) Adenocarcinoma

✍ Iveson, T.; Donehower, R.C.; Davidenko, I.; Tjulandin, S.; Deptala, A.; Harrison 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

749 POSTER Combination chemotherapy with

749 POSTER Combination chemotherapy with capecitabine (X) and cisplatin (P) as a first line treatment of advanced gastric cancer: experience of 246 patients with prognostic factor analysis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

6563 Phase I dose-finding study of soraf

6563 Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer

✍ Kim, C.; Lee, J.; Choi, Y.; Kang, B.; Ryu, M.; Ryoo, B.; Chang, H.; Kim, T.; Kan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB